Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Annual Review of Medicine|September 20, 2023
New Biological Therapies for Multiple MyelomaAlfred L GarfallHematology. American Society of Hematology. Education Program|December 4, 2016
Cellular and vaccine immunotherapy for multiple myelomaAlfred L Garfall, Edward A StadtmauerBlood Cancer Discovery|September 28, 2023
Understanding Infection Risk with Anti-BCMA Bispecific AntibodiesAlfred L Garfall, Edward A StadtmauerCase Reports in Oncological Medicine|December 30, 2014
A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib, dexamethasone, and dasatinibSamer Alsidawi, Abhimanyu Ghose, Julianne Qualtieri, et al.Hematology. American Society of Hematology. Education Program|December 9, 2023
Options at the time of relapse after anti-BCMA therapyBeatrice Razzo, Alfred L Garfall, Adam D CohenCancer Journal (Sudbury, Mass.)|February 4, 2016
The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic MalignanciesSarah J Nagle, Alfred L Garfall, Edward A StadtmauerDiscovery Medicine|January 14, 2014
Immunotherapy with chimeric antigen receptors for multiple myelomaAlfred L Garfall, Joseph A Fraietta, Marcela V MausOncotargets and Therapy|March 7, 2022
Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of TazemetostatRuben Raychaudhuri, Chaitra UjjaniJournal of Cardiology Cases|December 12, 2018
Left atrial thrombus mimicking atrial myxoma on imaging studies in a patient with cardiac transplantNaseer Khan, Anita Whitton, Russell Hoffman, et al.American Journal of Hematology|February 8, 2019
Chimeric antigen receptor T cell immunotherapy for multiple myeloma: A review of current data and potential clinical applicationsSandra P Susanibar Adaniya, Adam D Cohen, Alfred L GarfallPageof 10